Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-065712
Filing Date
2025-05-07
Accepted
2025-05-07 16:20:58
Documents
71
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nuvb-20250331.htm   iXBRL 10-Q 2561470
2 EX-10.1 nuvb-ex10_1.htm EX-10.1 305390
3 EX-10.3 nuvb-ex10_3.htm EX-10.3 438020
4 EX-10.4 nuvb-ex10_4.htm EX-10.4 439485
5 EX-31.1 nuvb-ex31_1.htm EX-31.1 17905
6 EX-31.2 nuvb-ex31_2.htm EX-31.2 17995
7 EX-32.1 nuvb-ex32_1.htm EX-32.1 9434
8 EX-32.2 nuvb-ex32_2.htm EX-32.2 8196
  Complete submission text file 0000950170-25-065712.txt   11401076

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nuvb-20250331.xsd EX-101.SCH 1264226
73 EXTRACTED XBRL INSTANCE DOCUMENT nuvb-20250331_htm.xml XML 1928707
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39351 | Film No.: 25921740
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)